High-risk ACS patients and cardiac biomarkers in the emergency department: Any role for new biomarkers of myocardial ischaemia? Reply [4]

European Heart Journal

Volumn 28, Issue 18, 2007, Pages 2297-2298

  Bagwe, Suveer ^a   Sachdeva, Rajesh ^a   Mehta, Jawahar L ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CHOLINE; FATTY ACID; GLYCOGEN PHOSPHORYLASE; ISOENZYME; TROPONIN;

ACUTE CORONARY SYNDROME; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY SPASM; DIAGNOSTIC PROCEDURE; DISEASE MARKER; EARLY DIAGNOSIS; EMERGENCY WARD; EVIDENCE BASED PRACTICE; GOLD STANDARD; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; LETTER; PRIORITY JOURNAL; RISK FACTOR; STABLE ANGINA PECTORIS; STANDARDIZATION; THORAX PAIN;

EID: 34548731440     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm317     Document Type: Letter

References (4)

1. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic event. Circulation 2004;109(25 Suppl. 1): IV6-IV19.
2. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005; 51:810-824.
3. Mehta JL. Oxidized or native LDL-cholesterol-Which is more important in atherogenesis? (Editorial) J Am Coll Cardiol 2006;48:980-982.
4. Parikh SV, de Lemos JA. Biomarkers in cardiovascular disease: integrating pathophysiology into clinical practice. Am J Med Sci 2006; 332(4):186-197.